Utility of Remote Lung Auscultation in Transitions of Care After Pulmonary Exacerbations of COPD - Trial NCT05661435

Timeline & Enrollment

Primary Outcome

Statistically significant associations between RESP Biosensor-acquired lung findings and 1) subjective measure of respiratory symptoms measured by validated measurements tools and 2) home spirometry

Summary

Listening to breath sounds with the stethoscope/auscultation is used by pulmonary physicians
 in conjunction with pulmonary function, signs and symptoms, oxygen saturation and diagnostic
 testing to admit, follow and discharge patients from hospital. Of these, only auscultation
 routinely ceases upon discharge from Hospital. Healthcare utilization statistics have shown
 that for more than a decade, readmission after discharge for an exacerbation of COPD or
 severe asthma (or chronic heart failure) remains a major problem. The Strados RESP Biosensor
 has been designed to extend the range of lung sound recording both geographically and
 temporally to improve the standard of care when access to continuous monitoring has been
 replaced by periodic or no monitoring. The primary purpose of this study is to assess the
 associations between RESP Biosensor-acquired lung findings and subjective measures of
 respiratory symptoms as measured by validated measurement tools, and objective measure of
 respiratory physiology as determined by home spirometry

ICD-10 Classifications